BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21871802)

  • 61. Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.
    Dawood S; Gonzalez-Angulo AM
    Oncologist; 2013 Jun; 18(6):675-84. PubMed ID: 23740934
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases.
    Li YS; Zheng MM; Jiang BY; Tu HY; Yang JJ; Zhang XC; Wu YL
    JAMA Netw Open; 2020 Aug; 3(8):e209077. PubMed ID: 32749467
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
    Cacho-Díaz B; Salmerón-Moreno K; Alvarez-Alvarez A; Mendoza-Olivas LG; Alvarado-Miranda A; Villarreal-Garza C; Reynoso-Noverón N; Chávez-MacGregor M; Meneses-García AA
    Cancer; 2020 Aug; 126(15):3456-3463. PubMed ID: 32453447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Breast cancer metastasis to the central nervous system.
    Weil RJ; Palmieri DC; Bronder JL; Stark AM; Steeg PS
    Am J Pathol; 2005 Oct; 167(4):913-20. PubMed ID: 16192626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Local and systemic therapy in breast cancer patients with central nervous system metastases.
    Wellerdieck NEA; Wessels P; Los M; Sonke GS; Tromp E; Brandsma D
    Breast Cancer Res Treat; 2022 Jul; 194(2):365-384. PubMed ID: 35680734
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.
    Baffert S; Cottu P; Kirova YM; Mercier F; Simondi C; Bachelot T; Le Rhun E; Levy C; Gutierrez M; Madranges N; Moldovan C; Coudert B; Spaëth D; Serin D; Cotté FE; Benjamin L; Maillard C; Laulhere-Vigneau S; Durand-Zaleski I
    BMC Health Serv Res; 2013 Oct; 13():456. PubMed ID: 24176086
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Spinal metastases in breast cancer: single center experience.
    Chan-Seng E; Charissoux M; Larbi A; Tétreau R; Gerber YN; De Verbizier-Lonjon D; Segnarbieux F; Lonjon N
    World Neurosurg; 2014 Dec; 82(6):1344-50. PubMed ID: 25118060
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort.
    Pasquier D; Darlix A; Louvel G; Fraisse J; Jacot W; Brain E; Petit A; Mouret-Reynier MA; Goncalves A; Dalenc F; Deluche E; Fresnel JS; Augereau P; Ferrero JM; Geffrelot J; Fumet JD; Lecouillard I; Cottu P; Petit T; Uwer L; Jouannaud C; Leheurteur M; Dieras V; Robain M; Mouttet-Audouard R; Bachelot T; Courtinard C
    Eur J Cancer; 2020 Jan; 125():22-30. PubMed ID: 31835235
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study.
    Simsek M; Aliyev A; Baydas T; Besiroglu M; Demir T; Shbair AT; Seker M; Turk HM
    Breast J; 2022; 2022():5763810. PubMed ID: 36051468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).
    Pestalozzi BC; Zahrieh D; Price KN; Holmberg SB; Lindtner J; Collins J; Crivellari D; Fey MF; Murray E; Pagani O; Simoncini E; Castiglione-Gertsch M; Gelber RD; Coates AS; Goldhirsch A;
    Ann Oncol; 2006 Jun; 17(6):935-44. PubMed ID: 16603601
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management.
    Lin NU; Gaspar LE; Soffietti R
    Am Soc Clin Oncol Educ Book; 2017; 37():45-56. PubMed ID: 28561683
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review.
    Cormio G; Maneo A; Parma G; Pittelli MR; Miceli MD; Bonazzi C
    Ann Oncol; 1995 Jul; 6(6):571-4. PubMed ID: 8573536
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.
    Diamantopoulos LN; Khaki AR; Sonpavde GP; Venur VA; Yu EY; Wright JL; Grivas P
    Clin Genitourin Cancer; 2020 Jun; 18(3):e266-e276. PubMed ID: 32178979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Economic burden of central nervous system metastases in human epidermal growth factor receptor 2-positive breast cancer.
    Schwartz NR; DeBusk K; Forero-Torres A; Feliciano J; Anupindi VR; Yeaw J; McBride A
    Future Oncol; 2021 Sep; 17(26):3457-3463. PubMed ID: 34044579
    [No Abstract]   [Full Text] [Related]  

  • 75. Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.
    Bashour SI; Ibrahim NK; Schomer DF; Hess KR; Gao C; Tripathy D; Fuller GN
    Br J Cancer; 2020 Oct; 123(9):1417-1423. PubMed ID: 32747747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Central nervous system metastasis in breast cancer.
    Boogerd W
    Radiother Oncol; 1996 Jul; 40(1):5-22. PubMed ID: 8844883
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence, clinicopathological characteristics, and therapeutic strategy for gastric cancer patients with metastasis to the central nervous system.
    Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e195-e201. PubMed ID: 35791882
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advanced hormone receptor-positive/human epidermal growth factor receptor 2-positive invasive ductal carcinoma with cecal metastasis: A case report.
    Yang SY; Zhang J; Yang ZQ; Duan JJ; Zhang Y; Li MK; Wang L; Ye CM; Nie JY
    Sci Prog; 2023; 106(4):368504231201043. PubMed ID: 37828835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Brain-metastatic Breast Cancer: Clinical Considerations and Pharmacological Approaches.
    Andrade AC; Ferruzzi DS; Panis C
    Anticancer Agents Med Chem; 2016; 16(12):1523-1528. PubMed ID: 27039922
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Central nervous system metastasis from breast carcinoma. Autopsy study.
    Tsukada Y; Fouad A; Pickren JW; Lane WW
    Cancer; 1983 Dec; 52(12):2349-54. PubMed ID: 6640506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.